Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 2
1961 3
1963 1
1964 2
1969 1
1970 1
1971 4
1972 1
1973 1
1975 4
1983 1
1988 1
1989 2
1992 1
1994 1
1996 3
1998 1
1999 2
2000 3
2001 1
2002 2
2003 4
2004 2
2005 1
2006 3
2007 2
2008 6
2009 7
2011 2
2012 2
2013 1
2014 4
2015 7
2016 3
2017 4
2018 5
2019 5
2020 3
2021 6
2022 5
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Hiwase D, Hahn C, Tran ENH, Chhetri R, Baranwal A, Al-Kali A, Sharplin K, Ladon D, Hollins R, Greipp P, Kutyna M, Alkhateeb H, Badar T, Wang P, Ross DM, Singhal D, Shanmuganathan N, Bardy P, Beligaswatte A, Yeung D, Litzow MR, Mangaonkar A, Giri P, Lee C, Yong A, Horvath N, Singhal N, Gowda R, Hogan W, Gangat N, Patnaik M, Begna K, Tiong IS, Wei A, Kumar S, Brown A, Scott H, Thomas D, Kok CH, Tefferi A, Shah MV. Hiwase D, et al. Among authors: horvath n. Blood. 2023 Mar 2;141(9):1087-1091. doi: 10.1182/blood.2022018236. Blood. 2023. PMID: 36574363 No abstract available.
Circulating tumour DNA analysis predicts relapse and improves risk stratification in primary refractory multiple myeloma.
Mithraprabhu S, Reynolds J, Turner R, Quach H, Horvath N, Kerridge I, Kalff A, Bergin K, Hocking J, Yuen F, Khong T, Durie BM, Spencer A. Mithraprabhu S, et al. Among authors: horvath n. Blood Cancer J. 2023 Feb 13;13(1):25. doi: 10.1038/s41408-023-00796-9. Blood Cancer J. 2023. PMID: 36781844 Free PMC article. No abstract available.
Spironolactone and agranulocytosis.
Hui CH, Das PK, Horvath N. Hui CH, et al. Among authors: horvath n. Aust N Z J Med. 2000 Aug;30(4):515. doi: 10.1111/j.1445-5994.2000.tb02066.x. Aust N Z J Med. 2000. PMID: 10985525 No abstract available.
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Weber N, Mollee P, Augustson B, Brown R, Catley L, Gibson J, Harrison S, Ho PJ, Horvath N, Jaksic W, Joshua D, Quach H, Roberts AW, Spencer A, Szer J, Talaulikar D, To B, Zannettino A, Prince HM. Weber N, et al. Among authors: horvath n. Intern Med J. 2015 Apr;45(4):371-82. doi: 10.1111/imj.12566. Intern Med J. 2015. PMID: 25169210 Review.
Treatment of patients with multiple myeloma who are eligible for stem cell transplantation: position statement of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Quach H, Joshua D, Ho J, Szer J, Spencer A, Harrison SJ, Mollee P, Roberts AW, Horvath N, Talaulikar D, To B, Zannettino A, Brown R, Catley L, Augustson B, Jaksic W, Gibson J, Prince HM. Quach H, et al. Among authors: horvath n. Intern Med J. 2015 Jan;45(1):94-105. doi: 10.1111/imj.12640. Intern Med J. 2015. PMID: 25582938 Review.
Myeloma stem cells in autografting in multiple myeloma.
To LB, Horvath N, Dyson P, Henry J, Sykes P, Brisco M, Morley A, Bennetts B. To LB, et al. Among authors: horvath n. J Hematother. 1996 Oct;5(5):557-9. doi: 10.1089/scd.1.1996.5.557. J Hematother. 1996. PMID: 8938529 Review.
Osteonecrosis of the jaw complicating bisphosphonate treatment for bone disease in multiple myeloma: an overview with recommendations for prevention and treatment.
Dickinson M, Prince HM, Kirsa S, Zannettino A, Gibbs SD, Mileshkin L, O'Grady J, Seymour JF, Szer J, Horvath N, Joshua DE. Dickinson M, et al. Among authors: horvath n. Intern Med J. 2009 May;39(5):304-16. doi: 10.1111/j.1445-5994.2008.01824.x. Epub 2008 Nov 3. Intern Med J. 2009. PMID: 19220531 Review.
Treatment of patients with multiple myeloma who are not eligible for stem cell transplantation: position statement of the myeloma foundation of Australia Medical and Scientific Advisory Group.
Quach H, Joshua D, Ho J, Szer J, Spencer A, Harrison S, Mollee P, Roberts A, Horvath N, Talaulikar D, To B, Zannettino A, Brown R, Catley L, Augustson B, Jaksic W, Gibson J, Prince HM. Quach H, et al. Among authors: horvath n. Intern Med J. 2015 Mar;45(3):335-43. doi: 10.1111/imj.12688. Intern Med J. 2015. PMID: 25735577 Review.
105 results